pLenti CMV Puro DEST (w118-1) TSPAN9 Citations (1)
Originally described in: PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.Aries IM, Bodaar K, Karim SA, Chonghaile TN, Hinze L, Burns MA, Pfirrmann M, Degar J, Landrigan JT, Balbach S, Peirs S, Menten B, Isenhart R, Stevenson KE, Neuberg DS, Devidas M, Loh ML, Hunger SP, Teachey DT, Rabin KR, Winter SS, Dunsmore KP, Wood BL, Silverman LB, Sallan SE, Van Vlierberghe P, Orkin SH, Knoechel B, Letai AG, Gutierrez A J Exp Med. 2018 Nov 7. pii: jem.20180570. doi: 10.1084/jem.20180570. PubMed Journal
Articles Citing pLenti CMV Puro DEST (w118-1) TSPAN9
| Articles |
|---|
| Serine/arginine-rich splicing factor 7 promotes the type I interferon response by activating Irf7 transcription. Scott HM, Smith MH, Coleman AK, Armijo KS, Chapman MJ, Apostalo SL, Wagner AR, Watson RO, Patrick KL. Cell Rep. 2024 Mar 26;43(3):113816. doi: 10.1016/j.celrep.2024.113816. Epub 2024 Feb 22. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.